GTI Resources kicks off exploration at Meekatharra VMS Project

|

Published 27-JUN-2018 12:21 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

GTI Resources (ASX:GTR) is set to kick off on-ground exploration at its Meekatharra VMS Project in WA’s Eastern Goldfields, targeting Volcanic Massive Sulphide (VMS) style base metal mineralisation.

This exploration campaign is fully funded by recently completed capital raisings.

The Meekatharra Project is situated 55 kilometres south of Meekatharra, and is underlain by a sequence of mafic and felsic volcanics, which host a number of VMS base metal prospects and deposits, within and adjacent GTR’s project — these include the Austin VMS deposit, which is located within an excised licence in the southern-central part of the project area, as well as the Murchison Wonder, Tasman and Flinders prospects to the northeast.

The Austin VMS deposit contains a JORC-compliant mineral Resource, comprising Measured, Indicated and Inferred categories of 1.48 Mt at 1.02 per cent copper, 1.39 per cent zinc, 3.51 grams per tonne silver and 0.25 grams per tonne gold.

Exploration by earlier workers identified two VMS prospects within the Meekatharra Project — the Defiance and 4E prospects, which have returned anomalous copper and zinc results, including 4m at 0.18 per cent copper, 8m at 0.34 per cent zinc and 10m at 0.23 per cent copper, from first pass drilling completed during 2010.

Exploration of these two prospects is at an early stage, with only three RC drill holes having been completed to a maximum depth of 252 metres.

Upcoming exploration will target VMS mineralisation at both of these prospects. On-ground exploration will comprise Moving Loop EM and field mapping.

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

The Defiance prospect is located 2 kilometres northeast of the Austin VMS deposit and is defined by a series of distinct east-northeast trending aeromagnetic anomalies over a one-kilometre strike length. Historical aircore drilling intersected anomalous zinc elevated copper values within ferruginous saprolite.

RC drill hole WKRC-4 targeted the centre of the Defiance prospect. The hole intersected a zone of interlayered silica–magnetite ironstones and chlorite-altered felsic volcanic rocks with significant stringer and disseminated sulphides, between 136 and 156m. Assay results include 4m at 0.17 per cent copper from 144 to 148m, and 8m at 0.34 per cent zinc from 148 to 156m.

The 4E prospect, on the other hand, is located 2 kilometres along strike to the east of the Defiance prospect and occurs as a bulls-eye magnetic feature approximately 400 metres in diameter.

GTR’s on-ground exploration programs will target the prospective felsic lithologies along strike to the northeast of the Austin deposit and to the east of the Defiance and 4E prospects.

On top of this, GTR continues to hold preliminary discussions with interested parties relating to new mining opportunities.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X